MGIM
BMRA icon

M&G Investment Management’s Biomerica BMRA Stock Holding History

M&G Investment Management’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,401
Closed -$816 – 517
2021
Q3 		$816 Hold
20,401
– – ﹤0.01% 647
2021
Q2 		$653 Buy
+20,401
New +$692K ﹤0.01% 661

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

M&G Investment Management's BMRA Position: Q4 2021 in Review

M&G Investment Management sold out of Biomerica (BMRA) in Q4 2021, closing a stake of 20,401 shares — an estimated $816 sold.

M&G Investment Management first reported a position in BMRA in Q2 2021 and held it in 2 quarters. The position peaked at $816 in Q3 2021. 24 funds tracked by Wall St. Rank hold BMRA as of Q4 2021.

  • M&G Investment Management reported no remaining Biomerica position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 20,401 Biomerica shares in Q4 2021, an estimated $816.
  • M&G Investment Management first reported a position in Biomerica in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Biomerica position peaked at $816 in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Biomerica as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.